MEOH Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Methanex Corp (MEOH) is not a strong buy at the moment for a long-term beginner investor. While the stock has some positive catalysts, such as elevated price targets and favorable analyst ratings, the financial performance is weak, technical indicators are neutral to bearish, and recent insider activity suggests selling pressure. Given the investor's preference for long-term growth, it is better to hold off on buying until there are stronger financial and technical signals.
The MACD histogram is negative (-0.311) and contracting, indicating bearish momentum. RSI is neutral at 60.32, and moving averages are converging, signaling no clear trend. Key resistance levels are at 61.051 and 63.279, while support levels are at 57.445 and 53.839. The stock is trading near resistance, suggesting limited upside potential in the short term.
Analysts from Scotiabank, UBS, and BMO Capital have raised price targets to $70, citing elevated free cash flow and higher methanol prices.
Methanol supply constraints in the Middle East and other regions are supporting higher spot prices, which could benefit Methanex in the near term.
OCI Chemicals B.V. has been selling significant shares of Methanex, reducing its stake by 7.33 million shares recently, indicating potential selling pressure.
RBC Capital downgraded the stock to Sector Perform, citing valuation concerns and the potential normalization of methanol prices by year-end.
The stock has a 70% chance of declining by -2.52% in the next day, -1.51% in the next week, and -4.55% in the next month, based on candlestick pattern analysis.
In Q4 2025, Methanex's revenue increased by 2.09% YoY to $968.81 million. However, net income dropped significantly to -$88.76 million (-296.91% YoY), and EPS fell to -$1.15 (-249.35% YoY). Gross margin also declined by 43.58% YoY to 7.38%, indicating worsening profitability.
Analysts are generally positive, with Scotiabank, UBS, and BMO Capital maintaining Outperform or Buy ratings and raising price targets to $70. However, RBC Capital downgraded the stock to Sector Perform, citing valuation concerns and potential normalization of methanol prices.
